Aneurysmal subarachnoid hemorrhage (aSAH) is one of the most severe neurological
disorders, with a high mortality rate and severe disabling functional sequelae. Systemic …

Traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) are major contributors to
morbidity and mortality. Following the initial insult, patients may deteriorate due to secondary …

OBJECTIVE Stroke-associated immunosuppression and inflammation are increasingly
recognized as factors triggering infections and thus potentially influencing outcome after …

Background: Aneurysmal subarachnoid hemorrhage (aSAH) is still a fatal and morbid
disease, although bleeding aneurysms can be secured in almost all cases. Occurrence of …

Background Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage is
characterized by a highly complex pathophysiology and results in neurologic deterioration …

Abstract Interleukin 6 (IL-6) is a prominent proinflammatory cytokine and has been
discussed as a potential biomarker for delayed cerebral ischemia (DCI) following …

Interleukin 6 (IL-6) is a prominent proinflammatory cytokine. Neuroinflammation in general,
and IL-6 signaling in particular, appear to play a major role in the pathobiology and …

OBJECTIVE The aim of this study was to create prediction models for outcome parameters
by decision tree analysis based on clinical and laboratory data in patients with aneurysmal …

Objective Sarcopenia is defined as the loss of skeletal muscle mass and is considered an
important factor for clinical outcomes in various diseases. Recent studies have shown that …

Objective This study set out to investigate the relationships between the neutrophil-to-
albumin ratio (NAR) in the early stages of aneurysmal subarachnoid hemorrhage (aSAH) …